GaviLyte-H and Bisacodyl Bowel Prep Pack
RxNorm 1718991

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1718991 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: GaviLyte-H and Bisacodyl Bowel Prep Pack.

The following semantic concepts and normalized strings are associated with this clinical entity:

SY
Gavilyte-H and Bisacodyl Bowel Prep (PEG-3350 210 GM / sodium chloride 5.6 GM / sodium bicarbonate 2.86 GM / potassium chloride 0.74 GM) Powder for 2 L Oral Solution / 1 x bisacodyl Delayed Release Oral Tablet
AUI:7702814
View
PSN
GaviLyte-H and Bisacodyl Bowel Prep Pack
AUI:8728839
View
BPCK
{1 (bisacodyl 5 mg Delayed Release Oral Tablet) / 1 (2000 mL) (polyethylene glycol 3350 210000 mg / potassium chloride 740 mg / sodium bicarbonate 2860 mg / sodium chloride 5600 mg Powder for Oral Solution [Gavilyte-H]) } Pack [Gavilyte-H and Bisacodyl]
AUI:12373160
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SY

Synonym (SY):
Gavilyte-H and Bisacodyl Bowel Prep (PEG-3350 210 GM / sodium chloride 5.6 GM / sodium bicarbonate 2.86 GM / potassium chloride 0.74 GM) Powder for 2 L Oral Solution / 1 x bisacodyl Delayed Release Oral Tablet
(Atom ID: 7702814)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Gavilyte-H and Bisacodyl Bowel Prep (PEG-3350 210 GM / sodium chloride 5.6 GM / sodium bicarbonate 2.86 GM / potassium chloride 0.74 GM) Powder for 2 L Oral Solution / 1 x bisacodyl Delayed Release Oral Tablet
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1718991
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
7702814
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1718991
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
PSN

Prescribable Name (PSN):
GaviLyte-H and Bisacodyl Bowel Prep Pack
(Atom ID: 8728839)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
GaviLyte-H and Bisacodyl Bowel Prep Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1718991
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
8728839
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1718991
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
BPCK

Brand Name Pack (BPCK):
{1 (bisacodyl 5 mg Delayed Release Oral Tablet) / 1 (2000 mL) (polyethylene glycol 3350 210000 mg / potassium chloride 740 mg / sodium bicarbonate 2860 mg / sodium chloride 5600 mg Powder for Oral Solution [Gavilyte-H]) } Pack [Gavilyte-H and Bisacodyl]
(Atom ID: 12373160)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{1 (bisacodyl 5 MG Delayed Release Oral Tablet) / 1 (2000 ML) (polyethylene glycol 3350 210000 MG / potassium chloride 740 MG / sodium bicarbonate 2860 MG / sodium chloride 5600 MG Powder for Oral Solution [Gavilyte-H]) } Pack [Gavilyte-H and Bisacodyl]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1718991
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12373160
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
BPCK
Brand Name Pack ({# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name])
Source Code
1718991
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN HUMAN DRUG
US
Drug available for use in Humans

Patient Education

Polyethylene glycol-electrolyte solution (PEG-ES)


Polyethylene glycol-electrolyte solution (PEG-ES) is used to empty the colon (large intestine, bowel) before a colonoscopy (examination of the inside of the colon to check for colon cancer and other abnormalities) or barium enema (a test in which the colon is filled with a fluid and then x-rays are taken) so that the doctor will have a clear view of the walls of the colon. PEG-ES is in a class of medications called osmotic laxatives. It works by causing watery diarrhea so that the stool can be emptied from the colon. The medication also contains electrolytes to prevent dehydration and other serious side effects that may be caused by fluid loss as the colon is emptied.
[Learn More]


* Please review the disclaimer below.